Medicine and Dentistry
COVID-19
100%
Gestational Diabetes
80%
Oral Glucose Tolerance Test
66%
Diabetes
49%
Tropical Disease
45%
Diseases
32%
Non Communicable Disease
32%
Personalized Medicine
30%
Medical Care
30%
6 Diazo 5 Oxonorleucine
25%
Observational Study
24%
Prospective Cohort Study
22%
Digital Health
22%
Health Service
22%
Impaired Glucose Tolerance
20%
Patient with Diabetes
20%
Diabetic Retinopathy
20%
Medication Compliance
20%
Health Care Cost
20%
Division
20%
Chagas Disease
20%
Health Inequality
20%
Malignant Neoplasm
20%
Effectiveness Study
20%
Health Disparity
20%
Mental Health
20%
Secretion (Process)
15%
Glucose Test
13%
Single Nucleotide Polymorphism
10%
Prevalence
9%
Chronic Disease
6%
Comorbidity
6%
Antitrypanosomal Agent
6%
Adverse Outcome
6%
Insulin Sensitivity
6%
Diagnosis
6%
Cohort Analysis
6%
Diabetes Mellitus
5%
Capillary
5%
Family History
5%
Body Mass Index
5%
Insulin Release
5%
Infection
5%
Translational Research
5%
Cancer Research
5%
Triage
5%
Injury
5%
Cooperation
5%
Nursing and Health Professions
Pregnancy Diabetes Mellitus
60%
Oral Glucose Tolerance Test
41%
Non Communicable Disease
40%
Primary Health Care
27%
Glucometer
25%
Capillary
25%
Disease
24%
Health Outcomes
22%
Diagnostic Accuracy
22%
Public Health Service
20%
Health Practitioner
20%
Chlormadinone Acetate
20%
Diabetic Retinopathy
20%
Symptom
20%
Cluster Analysis
20%
Health Care Facility
20%
Tropical Disease
20%
Impaired Glucose Tolerance
20%
Glucose Blood Level
13%
Area under the Curve
13%
Gold Standard
12%
Nutrition Policy
12%
World Health Organization
10%
Artificial Respiration
9%
Health Service
8%
Intensive Care Unit
8%
Oxygen Therapy
8%
Health Equity
8%
Disease Exacerbation
8%
Sensitivity and Specificity
7%
Hospital
7%
Health Center
6%
Comorbidity
6%
Confidence Interval
6%
Prevalence
6%
Diabetes Mellitus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
83%
Tropical Disease
45%
Coronavirinae
40%
Chagas Disease
40%
Comorbidity
33%
Observational Study
25%
Chronic Disease
24%
Pregnancy Diabetes Mellitus
20%
Syndrome
20%
Injury
20%
Symptom
20%
Pandemic
20%
6 Diazo 5 Oxonorleucine
20%
Fatality
20%
SARS Coronavirus
19%
Infection
13%
Non Communicable Disease
12%
Chronic Kidney Failure
12%
Ebola Virus
10%
Benznidazole
10%
CD8 Antigen
8%
Disease Exacerbation
8%
Lethality
8%
Trypanosoma Cruzi
6%
Antitrypanosomal Agent
6%
Prevalence
5%
Fexinidazole
5%
Fosravuconazole
5%
